Larvol Delta - Press-release-Oncology-Venture-signs-agreement-to-outlicense-two-pipeline-assets-as-part-of-prioritized-portfolio-strategy

LiPlaCis (liposomal cisplatin) - Oncology Venture

glutathione PEGylated liposomal doxorubicin (2X-111) - Oncology Venture

https://www.globenewswire.com/news-release/2020/06/29/2054444/0/en/Press-release-Oncology-Venture-signs-agreement-to-out-license-two-pipeline-assets-as-part-of-prioritized-portfolio-strategy.html

Jun 29, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next